Hong Kong Screening Centre Limited

Hong Kong Screening Centre Limited (“HKSC”) is a company committed to provide early and accurate detection of inherited metabolic disorders in newborn babies. Its laboratory processes the babies’ urine specimens to screen for more than 100 metabolic disorders. HKSC is a subsidiary of Cordlife Group Limited, a consumer healthcare group across Asia headquartered in Singapore and listed on the mainboard of Singapore Exchange.